Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ohio TechAngel Fund II (OTAF II) is an angel investment fund managed by Rev1 Ventures, based in Columbus, Ohio. It is part of the Ohio TechAngel Funds, which constitute one of the largest angel investor groups in the United States. The fund focuses on providing seed and early-stage capital to high-growth technology startups located primarily in Ohio, with a significant investment concentration in the life sciences, medical devices, and healthcare technology sectors. OTAF II utilizes a member-led model where individual angel investors pool capital and expertise to mentor and scale portfolio companies through their critical early growth phases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ohio TechAngel Fund II.